Ipragliflozin L-proline: Clinical Trials

1 trial of Ipragliflozin L-proline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Ipragliflozin L-proline: new trials by email Literature Review of Ipragliflozin L-proline trials Research Report on Ipragliflozin L-proline

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Ipragliflozin L-proline, Metformin, Placebo - Type 2 Diabetes Mellitus
Phase 3CompletedAstellas Pharma Europe B.V.2682016-05-112024-11-12

Conditions studied

Diabetes Mellitus, Type 2 (1)

Sponsors

Astellas Pharma Europe B.V. (1)

Countries

Russia (1)

Results publications

PMID 31606880